Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue?

Have you been paying attention to shares of Poseida Therapeutics, Inc. (PSTX) ? Shares have been on the move with the stock up 282.9% over the past month. The stock hit a new 52-week high of $9.41 in the previous session. Poseida Therapeutics, Inc. has gained 179.2% since the start of the year compared to the 1.5% move for the Zacks Medical sector and the -6.3% return for the Zacks Medical - Biomedical and Genetics industry.What's Driving the Outperformance?The stock has a great record of positive earnings ...